

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.53531232 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.40303529 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.32476801 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.31575412 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.31575412 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23594722 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.22260808 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 5.22260808 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.06974554 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.75251782 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.75251782 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.60994149 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52358112 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.42166207 |
| 15 | fatty acid elongation (GO:0030497) | 4.38698281 |
| 16 | central nervous system myelination (GO:0022010) | 4.38588574 |
| 17 | axon ensheathment in central nervous system (GO:0032291) | 4.38588574 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.34934875 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.24570008 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.20839806 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.20839806 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.20839806 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.20839806 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.20839806 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.20839806 |
| 26 | low-density lipoprotein particle remodeling (GO:0034374) | 4.16055732 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.02088157 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.01773924 |
| 29 | cysteine metabolic process (GO:0006534) | 3.94853057 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93409953 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90810886 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.89452070 |
| 33 | very long-chain fatty acid metabolic process (GO:0000038) | 3.88233563 |
| 34 | response to interleukin-15 (GO:0070672) | 3.86609849 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84123480 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 3.81174622 |
| 37 | detection of other organism (GO:0098543) | 3.79001397 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 3.77274437 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76703465 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.75671861 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.75600482 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.74035401 |
| 43 | L-amino acid import (GO:0043092) | 3.71699161 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.67933950 |
| 45 | glutamate metabolic process (GO:0006536) | 3.66665983 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.65089057 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 3.64593019 |
| 48 | macromolecular complex remodeling (GO:0034367) | 3.64593019 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 3.64593019 |
| 50 | negative T cell selection (GO:0043383) | 3.63543046 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.63469231 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.63469231 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.63469231 |
| 54 | detection of bacterium (GO:0016045) | 3.59667587 |
| 55 | C4-dicarboxylate transport (GO:0015740) | 3.57323634 |
| 56 | neutrophil activation (GO:0042119) | 3.56728761 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.52096914 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.50082935 |
| 59 | respiratory burst (GO:0045730) | 3.49743869 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.47473059 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43371160 |
| 62 | short-chain fatty acid metabolic process (GO:0046459) | 3.41162260 |
| 63 | kynurenine metabolic process (GO:0070189) | 3.39852502 |
| 64 | tryptophan metabolic process (GO:0006568) | 3.39283633 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.37087571 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 3.33860017 |
| 67 | bile acid metabolic process (GO:0008206) | 3.31991117 |
| 68 | granulocyte activation (GO:0036230) | 3.29358560 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 3.27146588 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 3.26589470 |
| 71 | alanine transport (GO:0032328) | 3.26494546 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.25288205 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.25288205 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.24540446 |
| 75 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.24011511 |
| 76 | homocysteine metabolic process (GO:0050667) | 3.23854053 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23597117 |
| 78 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.22487056 |
| 79 | coenzyme catabolic process (GO:0009109) | 3.22076922 |
| 80 | gamma-aminobutyric acid transport (GO:0015812) | 3.21810891 |
| 81 | response to type I interferon (GO:0034340) | 3.21588236 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.19179934 |
| 83 | response to peptidoglycan (GO:0032494) | 3.18321689 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17870912 |
| 85 | cellular extravasation (GO:0045123) | 3.16754128 |
| 86 | T cell migration (GO:0072678) | 3.15340745 |
| 87 | cellular amino acid catabolic process (GO:0009063) | 3.14339155 |
| 88 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.14152781 |
| 89 | serine family amino acid catabolic process (GO:0009071) | 3.13834442 |
| 90 | amino acid import (GO:0043090) | 3.13716515 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 3.13051107 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11133959 |
| 93 | germinal center formation (GO:0002467) | 3.09926854 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09593387 |
| 95 | B cell mediated immunity (GO:0019724) | 3.08844242 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08401516 |
| 97 | leukocyte aggregation (GO:0070486) | 3.07931297 |
| 98 | positive regulation of interferon-alpha production (GO:0032727) | 3.07602120 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.07389858 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 3.06660583 |
| 101 | cholesterol biosynthetic process (GO:0006695) | 3.05645541 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 3.05414218 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05376738 |
| 104 | positive thymic T cell selection (GO:0045059) | 3.04999588 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04315255 |
| 106 | regulation of triglyceride catabolic process (GO:0010896) | 3.04070831 |
| 107 | ketone body metabolic process (GO:1902224) | 3.02477835 |
| 108 | interferon-gamma secretion (GO:0072643) | 3.00436708 |
| 109 | aspartate family amino acid catabolic process (GO:0009068) | 2.99903591 |
| 110 | lysine catabolic process (GO:0006554) | 2.99734043 |
| 111 | lysine metabolic process (GO:0006553) | 2.99734043 |
| 112 | dendritic cell migration (GO:0036336) | 2.99581706 |
| 113 | cellular biogenic amine catabolic process (GO:0042402) | 2.99244937 |
| 114 | amine catabolic process (GO:0009310) | 2.99244937 |
| 115 | acyl-CoA biosynthetic process (GO:0071616) | 2.98395303 |
| 116 | thioester biosynthetic process (GO:0035384) | 2.98395303 |
| 117 | tyrosine metabolic process (GO:0006570) | 2.98215579 |
| 118 | regulation of cholesterol metabolic process (GO:0090181) | 2.97886259 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.97236496 |
| 120 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96575611 |
| 121 | ethanol oxidation (GO:0006069) | 2.96454455 |
| 122 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95402295 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.94440430 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.94420284 |
| 125 | cholesterol efflux (GO:0033344) | 2.93584083 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 2.93494622 |
| 127 | phospholipid efflux (GO:0033700) | 2.93021348 |
| 128 | linoleic acid metabolic process (GO:0043651) | 2.92596205 |
| 129 | acetyl-CoA metabolic process (GO:0006084) | 2.92060895 |
| 130 | plasma lipoprotein particle assembly (GO:0034377) | 2.90832601 |
| 131 | cellular glucuronidation (GO:0052695) | 2.90697620 |
| 132 | microglial cell activation (GO:0001774) | 2.90327963 |
| 133 | response to host immune response (GO:0052572) | 2.89608858 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89608858 |
| 135 | negative regulation of cholesterol transport (GO:0032375) | 2.89486945 |
| 136 | negative regulation of sterol transport (GO:0032372) | 2.89486945 |
| 137 | regulation of interferon-alpha production (GO:0032647) | 2.88891111 |
| 138 | urea cycle (GO:0000050) | 2.88483942 |
| 139 | urea metabolic process (GO:0019627) | 2.88483942 |
| 140 | detection of biotic stimulus (GO:0009595) | 2.87392049 |
| 141 | serine family amino acid biosynthetic process (GO:0009070) | 2.87219267 |
| 142 | heme transport (GO:0015886) | 2.86701276 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86576549 |
| 144 | negative regulation of astrocyte differentiation (GO:0048712) | 2.86484659 |
| 145 | L-serine metabolic process (GO:0006563) | 2.86185765 |
| 146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85257569 |
| 147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84942513 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.83877760 |
| 149 | cellular response to cholesterol (GO:0071397) | 2.83709750 |
| 150 | regulation of fibrinolysis (GO:0051917) | 2.83670807 |
| 151 | regulation of mast cell degranulation (GO:0043304) | 2.83099317 |
| 152 | regulation of bile acid biosynthetic process (GO:0070857) | 2.82771595 |
| 153 | T cell selection (GO:0045058) | 2.81292851 |
| 154 | macrophage activation (GO:0042116) | 2.80760476 |
| 155 | protein-lipid complex subunit organization (GO:0071825) | 2.79101197 |
| 156 | plasma lipoprotein particle clearance (GO:0034381) | 2.78346599 |
| 157 | protein carboxylation (GO:0018214) | 2.77067140 |
| 158 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.77067140 |
| 159 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.76747145 |
| 160 | drug catabolic process (GO:0042737) | 2.76532092 |
| 161 | negative regulation of fibrinolysis (GO:0051918) | 2.75767954 |
| 162 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75514809 |
| 163 | nitrogen cycle metabolic process (GO:0071941) | 2.75169980 |
| 164 | purine nucleotide transport (GO:0015865) | 2.75003495 |
| 165 | dicarboxylic acid catabolic process (GO:0043649) | 2.74679863 |
| 166 | regulation of protein activation cascade (GO:2000257) | 2.74257739 |
| 167 | organic acid catabolic process (GO:0016054) | 2.73947013 |
| 168 | carboxylic acid catabolic process (GO:0046395) | 2.73947013 |
| 169 | acyl-CoA metabolic process (GO:0006637) | 2.73331181 |
| 170 | thioester metabolic process (GO:0035383) | 2.73331181 |
| 171 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72468342 |
| 172 | regulation of T cell tolerance induction (GO:0002664) | 2.71897823 |
| 173 | complement activation, alternative pathway (GO:0006957) | 2.70846892 |
| 174 | positive T cell selection (GO:0043368) | 2.70761901 |
| 175 | L-serine transport (GO:0015825) | 2.70446993 |
| 176 | NIK/NF-kappaB signaling (GO:0038061) | 2.69612261 |
| 177 | negative regulation of innate immune response (GO:0045824) | 2.69174246 |
| 178 | regulation of cellular extravasation (GO:0002691) | 2.69129564 |
| 179 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.68735553 |
| 180 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.68735553 |
| 181 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67853032 |
| 182 | response to host (GO:0075136) | 2.67853032 |
| 183 | response to host defenses (GO:0052200) | 2.67853032 |
| 184 | thymic T cell selection (GO:0045061) | 2.67367898 |
| 185 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67134845 |
| 186 | protein-lipid complex assembly (GO:0065005) | 2.66339706 |
| 187 | serine family amino acid metabolic process (GO:0009069) | 2.66198784 |
| 188 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.66164058 |
| 189 | tolerance induction (GO:0002507) | 2.64552811 |
| 190 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64258169 |
| 191 | defense response to protozoan (GO:0042832) | 2.63414618 |
| 192 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.62706246 |
| 193 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.62706246 |
| 194 | regulation of tolerance induction (GO:0002643) | 2.62273068 |
| 195 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61753464 |
| 196 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.61729271 |
| 197 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.61514393 |
| 198 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.60979949 |
| 199 | leukocyte degranulation (GO:0043299) | 2.60400595 |
| 200 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.57523826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.30725223 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.29095329 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.07038970 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.04979498 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83086507 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.74240460 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67504995 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39554914 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.27837094 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14955560 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11830680 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10135799 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.96865624 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.94320363 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90387713 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73741882 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.73362377 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68847525 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67951135 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.64237156 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63617953 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61749104 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58164593 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.56355551 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41260317 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.24453415 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.21362440 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18725527 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.11967004 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11273328 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09187265 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.07902343 |
| 33 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.04890927 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.01244686 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.98110267 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96689817 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95496437 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93662816 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92110386 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92040947 |
| 41 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.91518781 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91285419 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90063152 |
| 44 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86799435 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85879591 |
| 46 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85661189 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83544237 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77809687 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.76779702 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.75982994 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75163041 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73366411 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.73110096 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.73110096 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72967507 |
| 56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71197172 |
| 57 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70035255 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70007657 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69750955 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66095198 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65417136 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.64798314 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64271340 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61763157 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61216767 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61145284 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60969801 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58435726 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58138186 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55985398 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54523649 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53086963 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52281313 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51539659 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50345508 |
| 76 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48005661 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47114123 |
| 78 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47094785 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45307142 |
| 80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.44280141 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43922583 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42185161 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40300729 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40176532 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40033964 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39623874 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.38529071 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36866385 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36632372 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36053372 |
| 91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30876296 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28517561 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28462319 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26263515 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23580153 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23548917 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22275872 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22117333 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21228342 |
| 100 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21027076 |
| 101 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20886833 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19848633 |
| 103 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19362601 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18827559 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17764534 |
| 106 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17141970 |
| 107 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16433887 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15454754 |
| 109 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15360130 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14987999 |
| 111 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14036860 |
| 112 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13265057 |
| 113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11772530 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10287297 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10287297 |
| 116 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09106693 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09053038 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08619650 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08593445 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08344005 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08030278 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07622093 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07146043 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06278612 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05905440 |
| 126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05593653 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05433580 |
| 128 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05014492 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02971365 |
| 130 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02803100 |
| 131 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02800291 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02255603 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02217041 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01836356 |
| 135 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01559005 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01447531 |
| 137 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01368668 |
| 138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00575948 |
| 139 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98745657 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97247597 |
| 141 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97107109 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96236654 |
| 143 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95772870 |
| 144 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95692886 |
| 145 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94956190 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94064406 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93833999 |
| 148 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93472000 |
| 149 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93283630 |
| 150 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91028159 |
| 151 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90088979 |
| 152 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90084689 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90069113 |
| 154 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.89564091 |
| 155 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88516410 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88428706 |
| 157 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88402100 |
| 158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88214420 |
| 159 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87613693 |
| 160 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87590451 |
| 161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87039569 |
| 162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86995197 |
| 163 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86285418 |
| 164 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86251976 |
| 165 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86107622 |
| 166 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85946082 |
| 167 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85694473 |
| 168 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84137951 |
| 169 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84118292 |
| 170 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83643966 |
| 171 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83398577 |
| 172 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82806046 |
| 173 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81697447 |
| 174 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81594824 |
| 175 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79878807 |
| 176 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79029319 |
| 177 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78291012 |
| 178 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78231346 |
| 179 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78184077 |
| 180 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78165074 |
| 181 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77710778 |
| 182 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77350425 |
| 183 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77227147 |
| 184 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.77227121 |
| 185 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.76981953 |
| 186 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76787587 |
| 187 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.76640619 |
| 188 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75523345 |
| 189 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74936347 |
| 190 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.74618426 |
| 191 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74224883 |
| 192 | AR_19668381_ChIP-Seq_PC3_Human | 0.73920940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.34437540 |
| 2 | MP0005360_urolithiasis | 5.00962192 |
| 3 | MP0003724_increased_susceptibility_to | 3.79505055 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.79367429 |
| 5 | MP0005365_abnormal_bile_salt | 3.67899637 |
| 6 | MP0003436_decreased_susceptibility_to | 3.54212164 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.49693174 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.44961670 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.29118247 |
| 10 | MP0005671_abnormal_response_to | 3.07001776 |
| 11 | MP0003690_abnormal_glial_cell | 3.05408653 |
| 12 | MP0000685_abnormal_immune_system | 2.90616861 |
| 13 | MP0001800_abnormal_humoral_immune | 2.82115794 |
| 14 | MP0003329_amyloid_beta_deposits | 2.79325398 |
| 15 | MP0009785_altered_susceptibility_to | 2.69062099 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.66370763 |
| 17 | MP0005332_abnormal_amino_acid | 2.61559784 |
| 18 | MP0003303_peritoneal_inflammation | 2.56971136 |
| 19 | MP0001790_abnormal_immune_system | 2.55966253 |
| 20 | MP0005387_immune_system_phenotype | 2.55966253 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.52369157 |
| 22 | MP0005025_abnormal_response_to | 2.51740566 |
| 23 | MP0002419_abnormal_innate_immunity | 2.50385998 |
| 24 | MP0009840_abnormal_foam_cell | 2.49908535 |
| 25 | MP0002723_abnormal_immune_serum | 2.45466026 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.39239099 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.35934528 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.29832695 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.29200969 |
| 30 | MP0001819_abnormal_immune_cell | 2.27821461 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.25382886 |
| 32 | MP0006082_CNS_inflammation | 2.18371848 |
| 33 | MP0004885_abnormal_endolymph | 2.16885079 |
| 34 | MP0003300_gastrointestinal_ulcer | 2.13275200 |
| 35 | MP0003866_abnormal_defecation | 2.09780344 |
| 36 | MP0003252_abnormal_bile_duct | 2.05465404 |
| 37 | MP0003195_calcinosis | 2.00254119 |
| 38 | MP0004859_abnormal_synaptic_plasticity | 1.99555713 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.95297848 |
| 40 | MP0000604_amyloidosis | 1.91356490 |
| 41 | MP0000920_abnormal_myelination | 1.91266483 |
| 42 | MP0004270_analgesia | 1.86687229 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.86273345 |
| 44 | MP0002405_respiratory_system_inflammati | 1.84329576 |
| 45 | MP0002398_abnormal_bone_marrow | 1.83263128 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.82272717 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.80052566 |
| 48 | MP0001486_abnormal_startle_reflex | 1.79793573 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.79472349 |
| 50 | MP0000716_abnormal_immune_system | 1.79209480 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.78258400 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.76120752 |
| 53 | MP0003136_yellow_coat_color | 1.74383463 |
| 54 | MP0003880_abnormal_central_pattern | 1.72687446 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.71536718 |
| 56 | MP0004947_skin_inflammation | 1.70178376 |
| 57 | MP0009046_muscle_twitch | 1.64587579 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.63378345 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.63311064 |
| 60 | MP0002064_seizures | 1.62146709 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.61566918 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.59115582 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.57676872 |
| 64 | MP0005083_abnormal_biliary_tract | 1.57633500 |
| 65 | MP0009745_abnormal_behavioral_response | 1.56678417 |
| 66 | MP0002722_abnormal_immune_system | 1.55088907 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.54620748 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 1.53248039 |
| 69 | MP0008469_abnormal_protein_level | 1.51792063 |
| 70 | MP0003011_delayed_dark_adaptation | 1.49887587 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.48156774 |
| 72 | MP0004043_abnormal_pH_regulation | 1.47378340 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44991611 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.44708017 |
| 75 | MP0002429_abnormal_blood_cell | 1.43903210 |
| 76 | MP0002272_abnormal_nervous_system | 1.43777930 |
| 77 | MP0008260_abnormal_autophagy | 1.43474145 |
| 78 | MP0002009_preneoplasia | 1.43288273 |
| 79 | MP0005310_abnormal_salivary_gland | 1.42743591 |
| 80 | MP0002822_catalepsy | 1.38120975 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.35035287 |
| 82 | MP0005451_abnormal_body_composition | 1.33123726 |
| 83 | MP0003868_abnormal_feces_composition | 1.32145587 |
| 84 | MP0002254_reproductive_system_inflammat | 1.31814555 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.31661968 |
| 86 | MP0002132_abnormal_respiratory_system | 1.31616650 |
| 87 | MP0009384_cardiac_valve_regurgitation | 1.31188457 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.31013774 |
| 89 | MP0001984_abnormal_olfaction | 1.29937552 |
| 90 | MP0001873_stomach_inflammation | 1.29628241 |
| 91 | MP0003634_abnormal_glial_cell | 1.28534507 |
| 92 | MP0002006_tumorigenesis | 1.28515426 |
| 93 | MP0004142_abnormal_muscle_tone | 1.26618034 |
| 94 | MP0001485_abnormal_pinna_reflex | 1.26386535 |
| 95 | MP0001905_abnormal_dopamine_level | 1.24405999 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 1.24027471 |
| 97 | MP0000858_altered_metastatic_potential | 1.22896088 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 1.21779892 |
| 99 | MP0002063_abnormal_learning/memory/cond | 1.21618448 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 1.20358738 |
| 101 | MP0003632_abnormal_nervous_system | 1.20092039 |
| 102 | MP0003633_abnormal_nervous_system | 1.19848823 |
| 103 | MP0005423_abnormal_somatic_nervous | 1.18888473 |
| 104 | MP0001502_abnormal_circadian_rhythm | 1.17873759 |
| 105 | MP0004742_abnormal_vestibular_system | 1.13849709 |
| 106 | MP0003631_nervous_system_phenotype | 1.12888446 |
| 107 | MP0003828_pulmonary_edema | 1.12702985 |
| 108 | MP0003878_abnormal_ear_physiology | 1.11108151 |
| 109 | MP0005377_hearing/vestibular/ear_phenot | 1.11108151 |
| 110 | MP0002229_neurodegeneration | 1.09108859 |
| 111 | MP0003075_altered_response_to | 1.08338653 |
| 112 | MP0009697_abnormal_copulation | 1.07938573 |
| 113 | MP0005171_absent_coat_pigmentation | 1.06669639 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 1.06583677 |
| 115 | MP0004858_abnormal_nervous_system | 1.06295722 |
| 116 | MP0005166_decreased_susceptibility_to | 1.04256226 |
| 117 | MP0001661_extended_life_span | 1.03555159 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 1.03271682 |
| 119 | MP0001501_abnormal_sleep_pattern | 1.03250025 |
| 120 | MP0002734_abnormal_mechanical_nocicepti | 1.02724261 |
| 121 | MP0000609_abnormal_liver_physiology | 1.02571856 |
| 122 | MP0004381_abnormal_hair_follicle | 1.01343370 |
| 123 | MP0002067_abnormal_sensory_capabilities | 0.99962218 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.99958493 |
| 125 | MP0005647_abnormal_sex_gland | 0.99458530 |
| 126 | MP0001529_abnormal_vocalization | 0.99289981 |
| 127 | MP0000569_abnormal_digit_pigmentation | 0.96077730 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.95149974 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.94913711 |
| 130 | MP0000566_synostosis | 0.94118555 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.93992588 |
| 132 | MP0009763_increased_sensitivity_to | 0.93838534 |
| 133 | MP0000490_abnormal_crypts_of | 0.93164958 |
| 134 | MP0001968_abnormal_touch/_nociception | 0.92970857 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.92516197 |
| 136 | MP0005535_abnormal_body_temperature | 0.91678248 |
| 137 | MP0002736_abnormal_nociception_after | 0.91158342 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.90949582 |
| 139 | MP0004924_abnormal_behavior | 0.90949582 |
| 140 | MP0005670_abnormal_white_adipose | 0.90463555 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.88221455 |
| 142 | MP0005164_abnormal_response_to | 0.86624215 |
| 143 | MP0009278_abnormal_bone_marrow | 0.86575527 |
| 144 | MP0001851_eye_inflammation | 0.86169002 |
| 145 | MP0003045_fibrosis | 0.86049890 |
| 146 | MP0001853_heart_inflammation | 0.85882347 |
| 147 | MP0004883_abnormal_blood_vessel | 0.85602312 |
| 148 | MP0008569_lethality_at_weaning | 0.85415756 |
| 149 | MP0001663_abnormal_digestive_system | 0.85053619 |
| 150 | MP0002090_abnormal_vision | 0.84423701 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.83073837 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.82980403 |
| 153 | MP0005397_hematopoietic_system_phenotyp | 0.82980403 |
| 154 | MP0000778_abnormal_nervous_system | 0.82042074 |
| 155 | MP0002557_abnormal_social/conspecific_i | 0.80898340 |
| 156 | MP0002066_abnormal_motor_capabilities/c | 0.78951727 |
| 157 | MP0001963_abnormal_hearing_physiology | 0.78791357 |
| 158 | MP0001765_abnormal_ion_homeostasis | 0.77941379 |
| 159 | MP0002733_abnormal_thermal_nociception | 0.77277780 |
| 160 | MP0001764_abnormal_homeostasis | 0.77058532 |
| 161 | MP0002876_abnormal_thyroid_physiology | 0.72726192 |
| 162 | MP0000955_abnormal_spinal_cord | 0.72059280 |
| 163 | MP0009764_decreased_sensitivity_to | 0.70469860 |
| 164 | MP0002882_abnormal_neuron_morphology | 0.70266171 |
| 165 | MP0004147_increased_porphyrin_level | 0.70063609 |
| 166 | MP0008874_decreased_physiological_sensi | 0.69931830 |
| 167 | MP0003186_abnormal_redox_activity | 0.67581999 |
| 168 | MP0002693_abnormal_pancreas_physiology | 0.67351437 |
| 169 | MP0009765_abnormal_xenobiotic_induced | 0.67195879 |
| 170 | MP0002971_abnormal_brown_adipose | 0.67000244 |
| 171 | MP0005645_abnormal_hypothalamus_physiol | 0.66754907 |
| 172 | MP0004808_abnormal_hematopoietic_stem | 0.66349303 |
| 173 | MP0002136_abnormal_kidney_physiology | 0.66276164 |
| 174 | MP0001970_abnormal_pain_threshold | 0.66192225 |
| 175 | MP0003448_altered_tumor_morphology | 0.65864050 |
| 176 | MP0000462_abnormal_digestive_system | 0.64291841 |
| 177 | MP0005410_abnormal_fertilization | 0.64081082 |
| 178 | MP0000639_abnormal_adrenal_gland | 0.63898793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.65730939 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.29630455 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.83246016 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.77346056 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.71903124 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.66278588 |
| 7 | Xanthomatosis (HP:0000991) | 4.60101485 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.53169381 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.44998018 |
| 10 | Myositis (HP:0100614) | 4.41545101 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.38414289 |
| 12 | Orchitis (HP:0100796) | 4.22567701 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.02020668 |
| 14 | Optic neuritis (HP:0100653) | 4.00635400 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.00635400 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.96587785 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96587785 |
| 18 | Hyperglycinuria (HP:0003108) | 3.86452803 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.79536594 |
| 20 | Hyperglycinemia (HP:0002154) | 3.68028815 |
| 21 | Stomatitis (HP:0010280) | 3.66893045 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.66217108 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63375835 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61874626 |
| 25 | Obstructive lung disease (HP:0006536) | 3.61874626 |
| 26 | T lymphocytopenia (HP:0005403) | 3.59951902 |
| 27 | Meningitis (HP:0001287) | 3.58875320 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.51907291 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49886347 |
| 30 | Abnormality of T cell number (HP:0011839) | 3.45780426 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.45066421 |
| 32 | Ketosis (HP:0001946) | 3.39129214 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 3.37427460 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.36451188 |
| 35 | Hyperammonemia (HP:0001987) | 3.35319538 |
| 36 | Encephalitis (HP:0002383) | 3.30288071 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27182794 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.22323381 |
| 39 | Vasculitis (HP:0002633) | 3.20906202 |
| 40 | Recurrent skin infections (HP:0001581) | 3.20533992 |
| 41 | Aplasia involving bones of the extremities (HP:0009825) | 3.18154092 |
| 42 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.18154092 |
| 43 | Aplasia of the phalanges of the hand (HP:0009802) | 3.18154092 |
| 44 | Hypolipoproteinemia (HP:0010981) | 3.15296054 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.15180928 |
| 46 | Abnormality of methionine metabolism (HP:0010901) | 3.13836591 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 3.11030082 |
| 48 | Chronic diarrhea (HP:0002028) | 3.10472827 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05020634 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05020634 |
| 51 | Abnormality of T cells (HP:0002843) | 3.01170650 |
| 52 | Recurrent viral infections (HP:0004429) | 3.00456092 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.99533002 |
| 54 | Pustule (HP:0200039) | 2.95060859 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.94899551 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93802362 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93628240 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.92189798 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.90380060 |
| 60 | Ketoacidosis (HP:0001993) | 2.87625652 |
| 61 | Gingivitis (HP:0000230) | 2.85905883 |
| 62 | Fat malabsorption (HP:0002630) | 2.85851678 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.84275750 |
| 64 | Complement deficiency (HP:0004431) | 2.81988146 |
| 65 | Gingival bleeding (HP:0000225) | 2.81746242 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.78887500 |
| 67 | Urticaria (HP:0001025) | 2.76774423 |
| 68 | Epidermoid cyst (HP:0200040) | 2.73981075 |
| 69 | Spastic paraparesis (HP:0002313) | 2.73854041 |
| 70 | Granulocytopenia (HP:0001913) | 2.73517584 |
| 71 | Osteomyelitis (HP:0002754) | 2.73506749 |
| 72 | Confusion (HP:0001289) | 2.71822338 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.71087253 |
| 74 | Increased IgM level (HP:0003496) | 2.66961604 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.65297401 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.61517163 |
| 77 | Cellulitis (HP:0100658) | 2.61391043 |
| 78 | Leukocytosis (HP:0001974) | 2.60929477 |
| 79 | Hemoptysis (HP:0002105) | 2.59854426 |
| 80 | Joint hemorrhage (HP:0005261) | 2.59587432 |
| 81 | Increased IgE level (HP:0003212) | 2.59098968 |
| 82 | Megalencephaly (HP:0001355) | 2.57047247 |
| 83 | Petechiae (HP:0000967) | 2.57011657 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.56355324 |
| 85 | Status epilepticus (HP:0002133) | 2.50880534 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 2.50819347 |
| 87 | Anorexia (HP:0002039) | 2.50372019 |
| 88 | Premature loss of primary teeth (HP:0006323) | 2.49354440 |
| 89 | Amyloidosis (HP:0011034) | 2.48577203 |
| 90 | Chest pain (HP:0100749) | 2.47322571 |
| 91 | Paraparesis (HP:0002385) | 2.47125474 |
| 92 | Hyperventilation (HP:0002883) | 2.44816357 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.43757105 |
| 94 | Epistaxis (HP:0000421) | 2.43058870 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42917195 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42917195 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42917195 |
| 98 | Pulmonary embolism (HP:0002204) | 2.42247018 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.41959554 |
| 100 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41361225 |
| 101 | Severe combined immunodeficiency (HP:0004430) | 2.41197390 |
| 102 | Abnormality of secondary sexual hair (HP:0009888) | 2.40564167 |
| 103 | Abnormality of the axillary hair (HP:0100134) | 2.40564167 |
| 104 | Synostosis involving the elbow (HP:0003938) | 2.38785457 |
| 105 | Humeroradial synostosis (HP:0003041) | 2.38785457 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.37950198 |
| 107 | Colitis (HP:0002583) | 2.37799318 |
| 108 | Arterial thrombosis (HP:0004420) | 2.37378365 |
| 109 | IgG deficiency (HP:0004315) | 2.35478153 |
| 110 | Myokymia (HP:0002411) | 2.34789376 |
| 111 | Vacuolated lymphocytes (HP:0001922) | 2.33240408 |
| 112 | Gangrene (HP:0100758) | 2.31646370 |
| 113 | Methylmalonic acidemia (HP:0002912) | 2.31398339 |
| 114 | Hypoglycemic coma (HP:0001325) | 2.31319388 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30836816 |
| 116 | Acute hepatic failure (HP:0006554) | 2.30677440 |
| 117 | Eosinophilia (HP:0001880) | 2.29364208 |
| 118 | Steatorrhea (HP:0002570) | 2.28921407 |
| 119 | Focal motor seizures (HP:0011153) | 2.27934202 |
| 120 | Increased circulating renin level (HP:0000848) | 2.27156376 |
| 121 | Vascular calcification (HP:0004934) | 2.25846902 |
| 122 | Malnutrition (HP:0004395) | 2.25058536 |
| 123 | Systemic lupus erythematosus (HP:0002725) | 2.23882057 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 2.22969630 |
| 125 | Joint swelling (HP:0001386) | 2.20646903 |
| 126 | Intention tremor (HP:0002080) | 2.19794039 |
| 127 | Abnormality of the pleura (HP:0002103) | 2.19668579 |
| 128 | Sensorimotor neuropathy (HP:0007141) | 2.19328579 |
| 129 | Methylmalonic aciduria (HP:0012120) | 2.18738457 |
| 130 | Purpura (HP:0000979) | 2.18176062 |
| 131 | Abnormality of eosinophils (HP:0001879) | 2.18009326 |
| 132 | Hypercholesterolemia (HP:0003124) | 2.17910665 |
| 133 | Supranuclear gaze palsy (HP:0000605) | 2.17341457 |
| 134 | Loss of speech (HP:0002371) | 2.16752932 |
| 135 | Lethargy (HP:0001254) | 2.15652794 |
| 136 | Combined immunodeficiency (HP:0005387) | 2.14281082 |
| 137 | Episodic fever (HP:0001954) | 2.14053554 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 2.12917443 |
| 139 | Abnormality of B cell number (HP:0010975) | 2.11862863 |
| 140 | Dicarboxylic aciduria (HP:0003215) | 2.11559081 |
| 141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11559081 |
| 142 | Sepsis (HP:0100806) | 2.10882145 |
| 143 | Gout (HP:0001997) | 2.10026944 |
| 144 | Hematochezia (HP:0002573) | 2.09830964 |
| 145 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.09473270 |
| 146 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.09473270 |
| 147 | Hepatosplenomegaly (HP:0001433) | 2.08649688 |
| 148 | Skin rash (HP:0000988) | 2.08609150 |
| 149 | Metabolic acidosis (HP:0001942) | 2.08002850 |
| 150 | Mucopolysacchariduria (HP:0008155) | 2.07814648 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07814648 |
| 152 | Clumsiness (HP:0002312) | 2.07584772 |
| 153 | IgM deficiency (HP:0002850) | 2.05576776 |
| 154 | Chronic otitis media (HP:0000389) | 2.04572899 |
| 155 | Recurrent sinusitis (HP:0011108) | 2.03644073 |
| 156 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03321445 |
| 157 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03272171 |
| 158 | Irritability (HP:0000737) | 2.03204557 |
| 159 | Recurrent pneumonia (HP:0006532) | 2.02504597 |
| 160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02427633 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02427633 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02427633 |
| 163 | Back pain (HP:0003418) | 2.01690063 |
| 164 | Parakeratosis (HP:0001036) | 1.98886011 |
| 165 | Abnormal gallbladder physiology (HP:0012438) | 1.98635370 |
| 166 | Cholecystitis (HP:0001082) | 1.98635370 |
| 167 | Abnormality of the corticospinal tract (HP:0002492) | 1.97503142 |
| 168 | Hyperbilirubinemia (HP:0002904) | 1.97275508 |
| 169 | Lymphopenia (HP:0001888) | 1.97003387 |
| 170 | Papilloma (HP:0012740) | 1.96914090 |
| 171 | Verrucae (HP:0200043) | 1.96914090 |
| 172 | Hemiparesis (HP:0001269) | 1.96207690 |
| 173 | Hypergammaglobulinemia (HP:0010702) | 1.95103783 |
| 174 | Hypoplastic left heart (HP:0004383) | 1.94908039 |
| 175 | Hypochromic anemia (HP:0001931) | 1.93969406 |
| 176 | Fatigue (HP:0012378) | 1.93917729 |
| 177 | Abnormality of vitamin metabolism (HP:0100508) | 1.93719762 |
| 178 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92485216 |
| 179 | Metabolic alkalosis (HP:0200114) | 1.91797333 |
| 180 | Alkalosis (HP:0001948) | 1.91438431 |
| 181 | Cardiovascular calcification (HP:0011915) | 1.89072964 |
| 182 | Hypophosphatemic rickets (HP:0004912) | 1.88616235 |
| 183 | Hemiplegia (HP:0002301) | 1.87872803 |
| 184 | Hypokalemic alkalosis (HP:0001949) | 1.86702571 |
| 185 | Enlarged kidneys (HP:0000105) | 1.85201676 |
| 186 | Abnormal gallbladder morphology (HP:0012437) | 1.83265480 |
| 187 | Abnormality of glycolysis (HP:0004366) | 1.83228267 |
| 188 | Increased serum pyruvate (HP:0003542) | 1.83228267 |
| 189 | Dysmetria (HP:0001310) | 1.79435353 |
| 190 | Diplopia (HP:0000651) | 1.79362150 |
| 191 | Abnormality of binocular vision (HP:0011514) | 1.79362150 |
| 192 | Pheochromocytoma (HP:0002666) | 1.78697865 |
| 193 | Abnormality of purine metabolism (HP:0004352) | 1.77756903 |
| 194 | Rickets (HP:0002748) | 1.76579424 |
| 195 | Abnormality of urine glucose concentration (HP:0011016) | 1.76415875 |
| 196 | Glycosuria (HP:0003076) | 1.76415875 |
| 197 | Hypoglycemic seizures (HP:0002173) | 1.75795738 |
| 198 | Cerebral edema (HP:0002181) | 1.75634684 |
| 199 | Spastic tetraparesis (HP:0001285) | 1.72725572 |
| 200 | Dysdiadochokinesis (HP:0002075) | 1.71788260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.67034571 |
| 2 | MAP4K1 | 3.65105295 |
| 3 | TNIK | 3.59339793 |
| 4 | STK39 | 3.52496978 |
| 5 | ERN1 | 3.40252218 |
| 6 | RIPK4 | 3.34297123 |
| 7 | OXSR1 | 3.31886353 |
| 8 | IRAK4 | 3.16857238 |
| 9 | TXK | 3.05354668 |
| 10 | TYK2 | 2.97663808 |
| 11 | MAP3K14 | 2.70049201 |
| 12 | BLK | 2.66196699 |
| 13 | MUSK | 2.59636936 |
| 14 | BCKDK | 2.40677157 |
| 15 | NTRK2 | 2.21856193 |
| 16 | CSK | 2.14776170 |
| 17 | PHKG2 | 2.07962430 |
| 18 | PHKG1 | 2.07962430 |
| 19 | ACVR1B | 2.05948905 |
| 20 | MAP2K3 | 2.05353542 |
| 21 | SIK1 | 1.96625401 |
| 22 | CASK | 1.92239417 |
| 23 | IKBKE | 1.88886606 |
| 24 | JAK3 | 1.86888920 |
| 25 | ZAP70 | 1.83738664 |
| 26 | LMTK2 | 1.82770115 |
| 27 | TESK2 | 1.81287639 |
| 28 | EPHB1 | 1.81102780 |
| 29 | TBK1 | 1.80718761 |
| 30 | WNK4 | 1.79052318 |
| 31 | BTK | 1.72649343 |
| 32 | SYK | 1.72099079 |
| 33 | NTRK1 | 1.63543053 |
| 34 | PBK | 1.61955412 |
| 35 | JAK1 | 1.60488784 |
| 36 | NTRK3 | 1.59389596 |
| 37 | SGK223 | 1.58275224 |
| 38 | SGK494 | 1.58275224 |
| 39 | ERBB4 | 1.57207122 |
| 40 | FGFR2 | 1.54405248 |
| 41 | PKN1 | 1.51380043 |
| 42 | INSRR | 1.48214453 |
| 43 | LYN | 1.46491369 |
| 44 | ITK | 1.44571997 |
| 45 | MAP3K2 | 1.41856409 |
| 46 | CSF1R | 1.41722655 |
| 47 | BMPR2 | 1.41490747 |
| 48 | HCK | 1.40934204 |
| 49 | MAP3K3 | 1.37574695 |
| 50 | MAP3K4 | 1.36562429 |
| 51 | MAP3K1 | 1.34476030 |
| 52 | MAP2K2 | 1.34184312 |
| 53 | MAP2K4 | 1.32275077 |
| 54 | TAOK1 | 1.30701341 |
| 55 | PINK1 | 1.29440813 |
| 56 | IKBKB | 1.26293197 |
| 57 | PAK6 | 1.23811064 |
| 58 | JAK2 | 1.21284645 |
| 59 | PRPF4B | 1.19655703 |
| 60 | LCK | 1.18141998 |
| 61 | MAP3K13 | 1.17729989 |
| 62 | PRKD3 | 1.17010218 |
| 63 | MAP3K11 | 1.15683680 |
| 64 | ICK | 1.14502965 |
| 65 | EPHA3 | 1.14406668 |
| 66 | FGFR3 | 1.14394119 |
| 67 | NEK6 | 1.12456958 |
| 68 | TYRO3 | 1.11458076 |
| 69 | MAP2K7 | 1.11135054 |
| 70 | CSNK1G2 | 1.10794645 |
| 71 | NLK | 1.08862851 |
| 72 | MATK | 1.08172146 |
| 73 | MET | 1.08102421 |
| 74 | PRKCG | 1.05982313 |
| 75 | TEC | 1.04531198 |
| 76 | MAP3K12 | 1.03394317 |
| 77 | CAMK2G | 1.02294922 |
| 78 | MAP2K6 | 1.00749483 |
| 79 | WNK1 | 1.00329527 |
| 80 | MARK1 | 0.99889334 |
| 81 | STK10 | 0.98317698 |
| 82 | CAMKK2 | 0.97564563 |
| 83 | FGR | 0.96397772 |
| 84 | SIK3 | 0.95665919 |
| 85 | MAPK15 | 0.95477620 |
| 86 | CAMK2A | 0.94009995 |
| 87 | WNK3 | 0.93232049 |
| 88 | MAPK12 | 0.92709868 |
| 89 | IRAK2 | 0.91909162 |
| 90 | ARAF | 0.91908997 |
| 91 | BCR | 0.91735629 |
| 92 | MINK1 | 0.90917537 |
| 93 | PRKCQ | 0.90827731 |
| 94 | CDK5 | 0.90183595 |
| 95 | MAPK13 | 0.90108079 |
| 96 | CDK19 | 0.90058460 |
| 97 | PDPK1 | 0.89967263 |
| 98 | TAOK3 | 0.89349424 |
| 99 | CAMK2B | 0.88841334 |
| 100 | MARK3 | 0.87891789 |
| 101 | YES1 | 0.87761275 |
| 102 | PAK3 | 0.87515766 |
| 103 | DAPK2 | 0.87357130 |
| 104 | SGK2 | 0.85820894 |
| 105 | MAP3K9 | 0.82316620 |
| 106 | CSNK1G3 | 0.79775802 |
| 107 | PRKCE | 0.77574111 |
| 108 | CAMK2D | 0.77226204 |
| 109 | KIT | 0.76219968 |
| 110 | PIM1 | 0.75272499 |
| 111 | ROCK2 | 0.74220221 |
| 112 | MAPK7 | 0.73527910 |
| 113 | FGFR4 | 0.72414525 |
| 114 | SGK3 | 0.70593431 |
| 115 | CSNK1G1 | 0.70409156 |
| 116 | SCYL2 | 0.68890283 |
| 117 | FES | 0.68617737 |
| 118 | IRAK3 | 0.68598714 |
| 119 | PIK3CG | 0.66734832 |
| 120 | PRKCH | 0.64120074 |
| 121 | UHMK1 | 0.63799092 |
| 122 | CSNK1A1L | 0.61738445 |
| 123 | MAPKAPK5 | 0.61364665 |
| 124 | PRKCZ | 0.61353087 |
| 125 | PASK | 0.60681758 |
| 126 | MAP3K7 | 0.60635888 |
| 127 | CDK4 | 0.58939076 |
| 128 | PRKAA2 | 0.58758233 |
| 129 | CAMK1G | 0.57074472 |
| 130 | TNK2 | 0.55474672 |
| 131 | PDK1 | 0.55346923 |
| 132 | MELK | 0.55303513 |
| 133 | KSR2 | 0.55162973 |
| 134 | PRKACG | 0.55126551 |
| 135 | PTK6 | 0.55084402 |
| 136 | TAOK2 | 0.53662633 |
| 137 | MST4 | 0.53597525 |
| 138 | CDC42BPA | 0.53396583 |
| 139 | PNCK | 0.52809553 |
| 140 | PRKCA | 0.52687990 |
| 141 | PRKACA | 0.51576171 |
| 142 | CDK6 | 0.50916667 |
| 143 | PDK2 | 0.49786898 |
| 144 | IRAK1 | 0.49678701 |
| 145 | ADRBK1 | 0.49353897 |
| 146 | SGK1 | 0.49349649 |
| 147 | PRKG1 | 0.49300259 |
| 148 | STK38 | 0.48819285 |
| 149 | MAPK11 | 0.47566860 |
| 150 | MAPKAPK2 | 0.46956303 |
| 151 | FYN | 0.46735555 |
| 152 | DYRK1A | 0.44993705 |
| 153 | GRK6 | 0.44535811 |
| 154 | MST1R | 0.44489427 |
| 155 | GRK7 | 0.44373005 |
| 156 | RAF1 | 0.44322252 |
| 157 | HIPK2 | 0.43811713 |
| 158 | GRK5 | 0.43528936 |
| 159 | LRRK2 | 0.42786440 |
| 160 | CDK15 | 0.42233690 |
| 161 | PRKACB | 0.41673411 |
| 162 | PRKG2 | 0.41561380 |
| 163 | FRK | 0.41506592 |
| 164 | MARK2 | 0.41349513 |
| 165 | ABL2 | 0.40987641 |
| 166 | KDR | 0.38276732 |
| 167 | TGFBR2 | 0.37716114 |
| 168 | CDK12 | 0.37056214 |
| 169 | RPS6KA4 | 0.36555645 |
| 170 | CAMKK1 | 0.35009869 |
| 171 | NEK9 | 0.34657239 |
| 172 | MAP3K5 | 0.33774511 |
| 173 | DYRK1B | 0.28940212 |
| 174 | STK11 | 0.27540124 |
| 175 | ABL1 | 0.27496199 |
| 176 | MAP3K8 | 0.27216122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.95321272 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.19364238 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.14731866 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.08769786 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83198290 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.60310871 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.57684495 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.56062596 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53405394 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.52831331 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44091201 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41936383 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35508476 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34682257 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32594092 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.30456612 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25397143 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23928160 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20813345 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20000173 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11670656 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11350676 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10898066 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09976380 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09699830 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08809544 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06315013 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04545035 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00839391 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97821553 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97533753 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95327578 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94055543 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.93358635 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.91214962 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89700580 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.87575508 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86708215 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.83138261 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80542991 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77458121 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76939692 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72490672 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.71678768 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71272435 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.68944552 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65346423 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64265829 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59004532 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51751906 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51017362 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50875610 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50832361 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.48599786 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.47065122 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45107595 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43053384 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42914375 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42792114 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41959865 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41556218 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34115296 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30637378 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28701360 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28329675 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25708598 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23123706 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23088252 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21750398 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19284292 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 1.18549997 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 1.18271816 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17517616 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16779299 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16554240 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15970385 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12885567 |
| 78 | Malaria_Homo sapiens_hsa05144 | 1.02370992 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02048992 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 1.01813020 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01598240 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98624276 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97985828 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.97575366 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93842317 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93612567 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.92969286 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91450555 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.91226433 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91196720 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.90730944 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89912631 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89142325 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88517812 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88421313 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88081834 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87390907 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87272473 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86018871 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.84102249 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84000901 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82275768 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.81860013 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81049888 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79504457 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77803100 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77789005 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77073793 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74345091 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71686497 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69659092 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68797071 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66171184 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.65103623 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62893172 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62092475 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60877050 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60688604 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60660912 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59731065 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.58722938 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57324152 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53936217 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53667595 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52705463 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52152360 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52105063 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51703829 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51045086 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.49467127 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48965181 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48707817 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48240178 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.48086595 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44696366 |
| 136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44488170 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.44323420 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43906793 |
| 139 | Morphine addiction_Homo sapiens_hsa05032 | 0.41927756 |
| 140 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40481835 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39263701 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38689865 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38161094 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37631896 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37604639 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37260272 |
| 147 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36808921 |
| 148 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33644160 |
| 149 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32829595 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32655441 |
| 151 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32197125 |
| 152 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31765280 |
| 153 | Lysine degradation_Homo sapiens_hsa00310 | 0.31303117 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31023746 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30542722 |
| 156 | Insulin secretion_Homo sapiens_hsa04911 | 0.30019946 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29922316 |
| 158 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27360860 |
| 159 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27014938 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.25703562 |
| 161 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25640251 |
| 162 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24243557 |
| 163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24052341 |
| 164 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20062448 |
| 165 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19806120 |
| 166 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18930250 |
| 167 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17207606 |
| 168 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16832371 |
| 169 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16107951 |
| 170 | Taste transduction_Homo sapiens_hsa04742 | 0.15594025 |

